nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylnaltrexone—OPRK1—Mecp2 and Associated Rett Syndrome—GAD1—type 1 diabetes mellitus	0.0392	0.0392	CbGpPWpGaD
Methylnaltrexone—OPRK1—Mecp2 and Associated Rett Syndrome—SST—type 1 diabetes mellitus	0.0284	0.0284	CbGpPWpGaD
Methylnaltrexone—OPRM1—IL4-mediated signaling events—CCL11—type 1 diabetes mellitus	0.0282	0.0282	CbGpPWpGaD
Methylnaltrexone—OPRM1—TCR Signaling Pathway—CBLB—type 1 diabetes mellitus	0.0238	0.0238	CbGpPWpGaD
Methylnaltrexone—OPRK1—Mecp2 and Associated Rett Syndrome—E2F1—type 1 diabetes mellitus	0.0196	0.0196	CbGpPWpGaD
Methylnaltrexone—OPRM1—Opioid Signalling—ITPR3—type 1 diabetes mellitus	0.0192	0.0192	CbGpPWpGaD
Methylnaltrexone—OPRM1—TCR Signaling Pathway—SH2B3—type 1 diabetes mellitus	0.0166	0.0166	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Melatonin metabolism and effects—ADRB1—type 1 diabetes mellitus	0.0158	0.0158	CbGpPWpGaD
Methylnaltrexone—OPRM1—IL4-mediated signaling events—IL10—type 1 diabetes mellitus	0.0139	0.0139	CbGpPWpGaD
Methylnaltrexone—OPRM1—IL4-mediated signaling events—CD40LG—type 1 diabetes mellitus	0.0139	0.0139	CbGpPWpGaD
Methylnaltrexone—OPRK1—Peptide ligand-binding receptors—GAL—type 1 diabetes mellitus	0.0138	0.0138	CbGpPWpGaD
Methylnaltrexone—OPRK1—Peptide ligand-binding receptors—CCL11—type 1 diabetes mellitus	0.0136	0.0136	CbGpPWpGaD
Methylnaltrexone—OPRK1—Peptide ligand-binding receptors—CCL20—type 1 diabetes mellitus	0.0136	0.0136	CbGpPWpGaD
Methylnaltrexone—OPRM1—IL4-mediated signaling events—IL4—type 1 diabetes mellitus	0.0135	0.0135	CbGpPWpGaD
Methylnaltrexone—OPRK1—Peptide GPCRs—CCR5—type 1 diabetes mellitus	0.0129	0.0129	CbGpPWpGaD
Methylnaltrexone—OPRM1—TCR Signaling Pathway—PRKCQ—type 1 diabetes mellitus	0.0124	0.0124	CbGpPWpGaD
Methylnaltrexone—OPRM1—TCR Signaling Pathway—VAV1—type 1 diabetes mellitus	0.0121	0.0121	CbGpPWpGaD
Methylnaltrexone—OPRM1—Peptide ligand-binding receptors—GAL—type 1 diabetes mellitus	0.0116	0.0116	CbGpPWpGaD
Methylnaltrexone—OPRK1—G alpha (i) signalling events—GAL—type 1 diabetes mellitus	0.0116	0.0116	CbGpPWpGaD
Methylnaltrexone—OPRM1—Peptide ligand-binding receptors—CCL20—type 1 diabetes mellitus	0.0115	0.0115	CbGpPWpGaD
Methylnaltrexone—OPRM1—Peptide ligand-binding receptors—CCL11—type 1 diabetes mellitus	0.0115	0.0115	CbGpPWpGaD
Methylnaltrexone—OPRK1—G alpha (i) signalling events—CCL20—type 1 diabetes mellitus	0.0115	0.0115	CbGpPWpGaD
Methylnaltrexone—OPRM1—Peptide GPCRs—CCR5—type 1 diabetes mellitus	0.0109	0.0109	CbGpPWpGaD
Methylnaltrexone—OPRK1—G alpha (i) signalling events—CHRM2—type 1 diabetes mellitus	0.0108	0.0108	CbGpPWpGaD
Methylnaltrexone—OPRM1—TCR Signaling Pathway—CD8A—type 1 diabetes mellitus	0.0102	0.0102	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCRs, Class A Rhodopsin-like—CHRM2—type 1 diabetes mellitus	0.01	0.01	CbGpPWpGaD
Methylnaltrexone—OPRM1—G alpha (i) signalling events—GAL—type 1 diabetes mellitus	0.00981	0.00981	CbGpPWpGaD
Methylnaltrexone—OPRM1—G alpha (i) signalling events—CCL20—type 1 diabetes mellitus	0.0097	0.0097	CbGpPWpGaD
Methylnaltrexone—OPRK1—Peptide ligand-binding receptors—SST—type 1 diabetes mellitus	0.00943	0.00943	CbGpPWpGaD
Methylnaltrexone—OPRM1—TCR Signaling Pathway—CCR5—type 1 diabetes mellitus	0.00934	0.00934	CbGpPWpGaD
Methylnaltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—GAL—type 1 diabetes mellitus	0.00923	0.00923	CbGpPWpGaD
Methylnaltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL11—type 1 diabetes mellitus	0.00913	0.00913	CbGpPWpGaD
Methylnaltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL20—type 1 diabetes mellitus	0.00913	0.00913	CbGpPWpGaD
Methylnaltrexone—OPRM1—G alpha (i) signalling events—CHRM2—type 1 diabetes mellitus	0.00912	0.00912	CbGpPWpGaD
Methylnaltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CHRM2—type 1 diabetes mellitus	0.00858	0.00858	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCRs, Class A Rhodopsin-like—CHRM2—type 1 diabetes mellitus	0.00847	0.00847	CbGpPWpGaD
Methylnaltrexone—OPRM1—Peptide ligand-binding receptors—SST—type 1 diabetes mellitus	0.00797	0.00797	CbGpPWpGaD
Methylnaltrexone—OPRK1—G alpha (i) signalling events—SST—type 1 diabetes mellitus	0.00796	0.00796	CbGpPWpGaD
Methylnaltrexone—OPRK1—Peptide ligand-binding receptors—CXCL10—type 1 diabetes mellitus	0.00784	0.00784	CbGpPWpGaD
Methylnaltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—GAL—type 1 diabetes mellitus	0.0078	0.0078	CbGpPWpGaD
Methylnaltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL11—type 1 diabetes mellitus	0.00771	0.00771	CbGpPWpGaD
Methylnaltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL20—type 1 diabetes mellitus	0.00771	0.00771	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCRs, Class A Rhodopsin-like—ADRB1—type 1 diabetes mellitus	0.00735	0.00735	CbGpPWpGaD
Methylnaltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CHRM2—type 1 diabetes mellitus	0.00725	0.00725	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—GAL—type 1 diabetes mellitus	0.00703	0.00703	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—CCL11—type 1 diabetes mellitus	0.00695	0.00695	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—CCL20—type 1 diabetes mellitus	0.00695	0.00695	CbGpPWpGaD
Methylnaltrexone—OPRM1—G alpha (i) signalling events—SST—type 1 diabetes mellitus	0.00673	0.00673	CbGpPWpGaD
Methylnaltrexone—OPRM1—Peptide ligand-binding receptors—CXCL10—type 1 diabetes mellitus	0.00662	0.00662	CbGpPWpGaD
Methylnaltrexone—OPRK1—G alpha (i) signalling events—CXCL10—type 1 diabetes mellitus	0.00661	0.00661	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—CHRM2—type 1 diabetes mellitus	0.00654	0.00654	CbGpPWpGaD
Methylnaltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—SST—type 1 diabetes mellitus	0.00633	0.00633	CbGpPWpGaD
Methylnaltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—ADRB1—type 1 diabetes mellitus	0.0063	0.0063	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCRs, Class A Rhodopsin-like—ADRB1—type 1 diabetes mellitus	0.00621	0.00621	CbGpPWpGaD
Methylnaltrexone—OPRK1—Peptide ligand-binding receptors—CCR5—type 1 diabetes mellitus	0.00608	0.00608	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—GAL—type 1 diabetes mellitus	0.00594	0.00594	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—CCL11—type 1 diabetes mellitus	0.00587	0.00587	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—CCL20—type 1 diabetes mellitus	0.00587	0.00587	CbGpPWpGaD
Methylnaltrexone—OPRM1—TCR Signaling Pathway—CD4—type 1 diabetes mellitus	0.00586	0.00586	CbGpPWpGaD
Methylnaltrexone—OPRM1—G alpha (i) signalling events—CXCL10—type 1 diabetes mellitus	0.00559	0.00559	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—CHRM2—type 1 diabetes mellitus	0.00552	0.00552	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—IAPP—type 1 diabetes mellitus	0.00549	0.00549	CbGpPWpGaD
Methylnaltrexone—OPRM1—TCR Signaling Pathway—IL1B—type 1 diabetes mellitus	0.00542	0.00542	CbGpPWpGaD
Methylnaltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—SST—type 1 diabetes mellitus	0.00535	0.00535	CbGpPWpGaD
Methylnaltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB1—type 1 diabetes mellitus	0.00532	0.00532	CbGpPWpGaD
Methylnaltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL10—type 1 diabetes mellitus	0.00526	0.00526	CbGpPWpGaD
Methylnaltrexone—OPRM1—Peptide ligand-binding receptors—CCR5—type 1 diabetes mellitus	0.00514	0.00514	CbGpPWpGaD
Methylnaltrexone—OPRK1—G alpha (i) signalling events—CCR5—type 1 diabetes mellitus	0.00513	0.00513	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—SST—type 1 diabetes mellitus	0.00482	0.00482	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—ADRB1—type 1 diabetes mellitus	0.0048	0.0048	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCRs, Class A Rhodopsin-like—CCR5—type 1 diabetes mellitus	0.00476	0.00476	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—IAPP—type 1 diabetes mellitus	0.00464	0.00464	CbGpPWpGaD
Methylnaltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL10—type 1 diabetes mellitus	0.00444	0.00444	CbGpPWpGaD
Methylnaltrexone—OPRM1—G alpha (i) signalling events—CCR5—type 1 diabetes mellitus	0.00433	0.00433	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—GCG—type 1 diabetes mellitus	0.00429	0.00429	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.00427	0.00427	CbGpPWpGaD
Methylnaltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	0.00408	0.00408	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—SST—type 1 diabetes mellitus	0.00407	0.00407	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—ADRB1—type 1 diabetes mellitus	0.00405	0.00405	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCRs, Class A Rhodopsin-like—CCR5—type 1 diabetes mellitus	0.00402	0.00402	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	0.004	0.004	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—GAL—type 1 diabetes mellitus	0.00397	0.00397	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	0.00393	0.00393	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	0.00369	0.00369	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—GCG—type 1 diabetes mellitus	0.00363	0.00363	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—GAL—type 1 diabetes mellitus	0.00361	0.00361	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—CCL11—type 1 diabetes mellitus	0.00357	0.00357	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—CCL20—type 1 diabetes mellitus	0.00357	0.00357	CbGpPWpGaD
Methylnaltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	0.00345	0.00345	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	0.00338	0.00338	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—GAL—type 1 diabetes mellitus	0.00336	0.00336	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	0.00335	0.00335	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	0.00332	0.00332	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	0.00332	0.00332	CbGpPWpGaD
Methylnaltrexone—OPRM1—TCR Signaling Pathway—IL6—type 1 diabetes mellitus	0.00317	0.00317	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	0.00312	0.00312	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—CCR5—type 1 diabetes mellitus	0.0031	0.0031	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	0.0031	0.0031	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—GAL—type 1 diabetes mellitus	0.00305	0.00305	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—CCL11—type 1 diabetes mellitus	0.00301	0.00301	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—CCL20—type 1 diabetes mellitus	0.00301	0.00301	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	0.00301	0.00301	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	0.00283	0.00283	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.00282	0.00282	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	0.0028	0.0028	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.00272	0.00272	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.00271	0.00271	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—CCR5—type 1 diabetes mellitus	0.00262	0.00262	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	0.00262	0.00262	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	0.00254	0.00254	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—SST—type 1 diabetes mellitus	0.00247	0.00247	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.00246	0.00246	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.00243	0.00243	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.00238	0.00238	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.00234	0.00234	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.0023	0.0023	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.00229	0.00229	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.00227	0.00227	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.00226	0.00226	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.0022	0.0022	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—GAL—type 1 diabetes mellitus	0.00213	0.00213	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.00212	0.00212	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.00211	0.00211	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.00211	0.00211	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—SST—type 1 diabetes mellitus	0.00209	0.00209	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.00208	0.00208	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.00206	0.00206	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.00205	0.00205	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.00205	0.00205	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.00198	0.00198	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.00197	0.00197	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.00192	0.00192	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.00191	0.00191	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.00186	0.00186	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—GAL—type 1 diabetes mellitus	0.0018	0.0018	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.00179	0.00179	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.00178	0.00178	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.00178	0.00178	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.00178	0.00178	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.00175	0.00175	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.00174	0.00174	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.00174	0.00174	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.00173	0.00173	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.00167	0.00167	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.00167	0.00167	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.00166	0.00166	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.00166	0.00166	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.00159	0.00159	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.00157	0.00157	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.0015	0.0015	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.00148	0.00148	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.00146	0.00146	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—HBA2—type 1 diabetes mellitus	0.00146	0.00146	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—SST—type 1 diabetes mellitus	0.00146	0.00146	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.00145	0.00145	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.00141	0.00141	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.00141	0.00141	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.00141	0.00141	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—G6PC2—type 1 diabetes mellitus	0.00137	0.00137	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.00135	0.00135	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.00133	0.00133	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—GCG—type 1 diabetes mellitus	0.0013	0.0013	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.00125	0.00125	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—SST—type 1 diabetes mellitus	0.00123	0.00123	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.00123	0.00123	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.00122	0.00122	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.00121	0.00121	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ABCC8—type 1 diabetes mellitus	0.00119	0.00119	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.00111	0.00111	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.0011	0.0011	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—GCG—type 1 diabetes mellitus	0.0011	0.0011	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CD86—type 1 diabetes mellitus	0.00106	0.00106	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.00106	0.00106	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.00103	0.00103	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.00103	0.00103	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.00101	0.00101	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.00101	0.00101	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000957	0.000957	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000942	0.000942	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000941	0.000941	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000935	0.000935	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000931	0.000931	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000928	0.000928	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000921	0.000921	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000897	0.000897	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.000857	0.000857	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000851	0.000851	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000809	0.000809	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000795	0.000795	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ITPR3—type 1 diabetes mellitus	0.000795	0.000795	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000784	0.000784	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000778	0.000778	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000774	0.000774	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—HBA1—type 1 diabetes mellitus	0.000748	0.000748	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—APOC3—type 1 diabetes mellitus	0.000743	0.000743	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—INS—type 1 diabetes mellitus	0.000732	0.000732	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—GSTT1—type 1 diabetes mellitus	0.00073	0.00073	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.000708	0.000708	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	0.000704	0.000704	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000654	0.000654	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.000654	0.000654	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.000641	0.000641	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—INS—type 1 diabetes mellitus	0.000618	0.000618	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.000598	0.000598	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	0.000595	0.000595	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—GCG—type 1 diabetes mellitus	0.000582	0.000582	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.000552	0.000552	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CASP3—type 1 diabetes mellitus	0.000545	0.000545	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—IL2—type 1 diabetes mellitus	0.000544	0.000544	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.000542	0.000542	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—IL6—type 1 diabetes mellitus	0.000541	0.000541	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—CAT—type 1 diabetes mellitus	0.000492	0.000492	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CASP3—type 1 diabetes mellitus	0.00046	0.00046	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—IL2—type 1 diabetes mellitus	0.00046	0.00046	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—STAT3—type 1 diabetes mellitus	0.000458	0.000458	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—IL6—type 1 diabetes mellitus	0.000457	0.000457	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—EGFR—type 1 diabetes mellitus	0.000416	0.000416	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—STAT3—type 1 diabetes mellitus	0.000387	0.000387	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—EGFR—type 1 diabetes mellitus	0.000352	0.000352	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—INS—type 1 diabetes mellitus	0.000327	0.000327	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—IL6—type 1 diabetes mellitus	0.00032	0.00032	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ALB—type 1 diabetes mellitus	0.0003	0.0003	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—NOS3—type 1 diabetes mellitus	0.000287	0.000287	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—IL6—type 1 diabetes mellitus	0.00027	0.00027	CbGpPWpGaD
